Methanobactins: Maintaining copper homeostasis in methanotrophs and beyond

Methanobactins (Mbns) are ribosomally produced, post-translationally modified natural products that bind copper with high affinity and specificity. Originally identified in methanotrophic bacteria, which have a high need for copper, operons encoding these compounds have also been found in many non-methanotrophic bacteria. The proteins responsible for Mbn biosynthesis include several novel enzymes. Mbn transport involves export through a multidrug efflux pump and re-internalization via a TonB-dependent transporter. Release of copper from Mbn and the molecular basis for copper regulation of Mbn production remain to be elucidated. Future work is likely to result in the identification of new enzymatic chemistry, opportunities for bioengineering and drug targeting of copper metabolism, and an expanded understanding of microbial metal homeostasis.

One of the best-understood examples is methanobactin (Mbn), a natural product involved in copper homeostasis in methanotrophic bacteria.
Methanotrophic bacteria oxidize methane to methanol in the first step of their metabolism (7). Two unrelated metalloenzymes catalyze aerobic methane oxidation (8), the cytoplasmic iron enzyme soluble methane monooxygenase (sMMO) and the more widespread copper enzyme particulate methane monooxygenase (pMMO), a integral inner membrane protein. Some methanotrophic bacteria can produce both enzymes, but whenever sufficient copper is present, sMMO is down-regulated and pMMO is preferred (9). In the presence of copper, methanotrophs produce extensive intracytoplasmic membranes (10,11). These membranes contain large quantities of pMMO, representing up to a fifth of the cellular protein mass (12). pMMO activity is copper-dependent (13), and methanotrophs thus have several systems for copper influx alongside the betterunderstood efflux systems of other microbes (14). Some methanotrophs secrete the posttranslationally modified protein MopE to bind extracellular copper (15), while other methanotrophs use the copper-binding "chalkophore" (from the Greek chalko-, copper) Mbn to mediate copper uptake into the intracellular copper pool (16,17). Mbns are ribosomally produced, posttranslationally modified natural products (RiPPs) (18). Operons encoding Mbn precursor peptides along with proteins involved in its biosynthesis, transport, and regulation have been identified in a range of bacteria, including non-methanotrophs, in which it is increasingly believed to play a similar role in copper homeostasis (19,20). Here we summarize the current state of knowledge regarding Mbns.

Mbn structures
The crystal structure of copper-loaded Mbn (CuMbn) from Methylosinus (Ms.) trichosporium OB3b was assigned as N-2isopropylester-(4-thionyl-5-hydroxy-imidazole)-Gly 1 -Ser 2 -Cys 3 -Tyr 4 -pyrrolidine-(4-hydroxy-5thionyl-imidazole)-Ser 5 -Cys 6 -Met 7 , with a disulfide bridge between the two cysteine residues (17). In this structure, two hydroxyimidazolate rings and neighboring thioamide groups coordinate a copper ion in a distorted tetrahedral geometry. Re-analysis by NMR provided two key corrections: the heterocycles are instead oxazolone rings and the "N-terminal" group is actually a 3methylbutanoyl group ( Figure 1A) (21). These oxazolone rings (and in some circumstances other nitrogen-containing heterocycles) and neighboring enethiol/thioamide groups are the core Mbn posttranslational modifications. Oxazolone rings contain an acid-labile lactone moiety, and Mbn is thus susceptible to acid-catalyzed methanolysis (21) and hydrolysis (22). The C-terminal methionine is sometimes absent (23), although it is unclear when and how this residue loss occurs. The structure of a second Ms. Mbn, Ms. sp. LW4 Mbn, was predicted based on its Mbn operon content; despite an otherwise divergent peptidic backbone, this Mbn has two oxazolone/thioamide pairs, an internal disulfide bond, and an N-terminal ketone group, as observed in Ms. trichosporium OB3b Mbn ( Figure 1B) (24).
CuMbn from Methylocystis (Mc.) sp. SB2, characterized by NMR, was reported to have a divergent peptidic backbone, no cysteinederived disulfide bond, and a sulfonated threonine as well as two heterocycle/thioamide moieties ( Figure 1C) (22). Several C-terminal residues are lost in the characterized compound (20). The first "N-terminal" heterocycle (heterocycle A) was deemed an imidazolone ring based on an NMRdetectable secondary amine embedded in that heterocycle (22). The second heterocycle (heterocycle B) is an oxazolone, as in Ms. trichosporium OB3b Mbn. Two additional Mbns from Mc. species have been characterized via X-ray crystallography and a third closely related Mbn via mass spectrometry (Figure 1D-F). Although these Mbns differ from Mc. sp. SB2 Mbn by only one or two residues, heterocycle A is clearly a sixmembered ring, depicted as a pyrazinediol group (25). Given that the Mc. species are closely related, the structural discrepancy in heterocycle A is puzzling (20). One explanation is that Mc. Mbns may actually contain a hydroxypyrazinone or pyrazinedione tautomer (Figure 1G), which would contain a heterocyclic secondary amine, as observed by NMR, and the six-membered rings observed via X-ray crystallography. Supporting this notion, the non-copper-chelating nitrogen in heterocycle A in the Mc. Mbn crystal structures appears to be protonated (24). Thioamide/enethiol tautomerization may also occur, depending on ionic state, copper chelation, and the identity of the neighboring heterocycle.

Mbns as metallophores
Mbns have a high affinity for copper in both oxidation states. Values vary significantly by measurement technique (28), but the broad consensus is that characterized Mbns have Cu(I) binding constants of at least 10 20 -10 21 M -1 (23,25,28,29). Structural modifications beyond the first coordination sphere such as loss of C-terminal residues or desulfonation of the threonine in Mc. Mbns slightly affect copper affinity (23,25). The Cu(I) affinity is high enough that Mbn can liberate bio-unavailable copper from sources ranging from humic acids (30) to minerals (31) to borosilicate glass (32,33). Although Mbns bind Cu(II) with lower affinity, generally calculated to be 10 11 -10 14 M -1 (25), binding is reductive, with conversion to Cu(I) within the first 10 min via an unknown mechanism, as confirmed by electron paramagnetic resonance and X-ray absorption spectroscopies (27,29,34,35). Under superstoichiometric copper conditions, a second copper binds, albeit with lower affinity and without reduction (29). Other stoichiometries are also observed under some conditions (29).
Like other metallophores, Mbns can bind additional metal ions. Harder metals, including Cd(II), Co(II), Fe(III), Mn(II), Ni(II), and Zn(II), bind Mbn poorly and sometimes as bischelates or as dimetallated compounds, and no reductive binding is observed (36). Softer metals such as Ag(I), Au(III), Hg(II), Pb(II), and U(VI) bind single Mbn molecules with a 1:1 stoichiometry. Recent IM-MS experiments complicate this classification of Mbn-metal interactions, although further spectroscopic analysis may be necessary to confirm these results (37). Nevertheless, binding of softer metals is consistently higher affinity, results in spectral features resembling those of CuMbn, and can be reductive for at least Au(III), Ag(I) and Hg(II) (36). Relative binding affinities show some pH dependence (36,37). However, reported binding constants for these metals are approximately five orders of magnitude lower than that for Cu(II) and fifteen orders of magnitude lower than that for Cu(I) (36). Despite this lower affinity, spectroscopic data suggest that bound Au(III), Ag(I) and Hg(II) are not readily displaced by copper (38,39). Metal binding has only been investigated extensively for Ms. trichosporium OB3b and Mc. sp. SB2 Mbns, but there are indications that relative affinities for metals other than copper may vary by Mbn (39).

Mbn operons
The peptidic Mbn backbone was originally thought to be the result of non-ribosomal peptide synthesis (NRPS) (40,41). However, a short open reading frame encoding a 30 amino acid peptide with 11 C-terminal residues resembling the Mbn backbone was identified in the Ms. trichosporium OB3b genome, suggesting a ribosomal origin (22), and disruption of this open reading frame abrogated Mbn production (42). Bioinformatic analyses identified related genes with similar genomic neighborhoods in other species (43), with 18 operons identified in 16 species by 2013 (19). To date, 74 Mbn operons have been found in 71 species, with Mbn operons in methanotrophs forming a minority (Figure 2A) (20). No Mbn operons are found in γ-proteobacterial methanotrophs; their reported Mbns may be other metallophores (19,35).
Mbn operon content varies considerably. Only three genes are found in all operons: mbnA, encoding the precursor peptide, and mbnB and mbnC, encoding hypothetical proteins with proposed roles in Mbn biosynthesis (19). Genes for membrane proteins related to Mbn import (TonBdependent transporters) and export (MATE multidrug export proteins) are found in many but not all operons. Beyond MbnB and MbnC, several groups of operons encode other biosynthesis proteins, including aminotransferases, predicted dioxygenases, flavoenzymes, sulfotransferases, and distant MbnB homologues, although none of these genes are widespread among Mbn operons.
Phylogenetic analysis of MbnA, MbnB, and MbnC yields six major Mbn subgroups (Figure 2B); these groups are also easily distinguished by their varying operon content (19) (Figure 2A). Groups I, IIa, and IIb are found exclusively in αproteobacterial methanotrophs belonging to the Methylosinus and Methylocystis genera, whereas Groups III, IV, and V are found in nonmethanotrophs ( Figure 2B). Group III operons are present in various proteobacteria, particularly Cupriavidus and Pseudomonas species. Group IV operons are found exclusively in Gluconacetobacter and related genera. Group V operons are found in a diverse range of species, including nonmethanotrophic proteobacteria as well as Grampositive Streptomyces species and even a Chlamydiales strain (20).

The biosynthetic pathway of Mbns
RiPPs originate as larger precursor peptides, containing both a "core" peptide which is the basis for the final natural product as well as "leader" peptide sequences that mediate interactions with biosynthetic enzymes and are lost during maturation (18). The MbnA precursor peptides are 22-35 aa in length (19,20). Almost all MbnA leader peptides contain several positively charged residues and a hydrophobic patch; Group V MbnAs also have negatively charged residues. The core peptides are more variable. The copperbinding oxazolones and thioamides derive from post-translationally modified cysteines (22), and only these cysteines are universal in core peptides (19). Not all cysteines in MbnAs are modified. A specific peptide sequence triggers modification: the target cysteine is followed by a small, often hydrophobic residue (alanine, glycine, or occa-sionally serine), and then a slightly larger, mildly hydrophilic residue (particularly serine and threonine) (19). Unmodified cysteines may form disulfide bonds, as in Ms. trichosporium OB3b and Ms. sp. LW4 Mbns (17,24).
The primary candidate proteins for oxazolone and thioamide biosynthesis are MbnB and MbnC (19). Neither belongs to a characterized protein family, although both are likely to be cytoplasmic, and MbnB is predicted to be a TIM barrel protein, with the closest characterized families comprising xylose isomerases and endonuclease IV enzymes. In some RiPP biosynthesis enzymes, a conserved RiPP Recognition Element (RRE) mediates enzyme/peptide interactions (44), but no RRE elements are found in MbnB, MbnC, or any other putative Mbn biosynthesis enzyme. Nevertheless, genes encoding MbnB and MbnC are present in all Mbn operons (Figure 2A) as a translationally coupled pair (20). No other biosynthesis proteins are universally present, and although a handful of other natural products contain oxazolone or thioamide groups, no homologues for any genes involved in biosynthesis of those compounds can be found in Mbn operons.
Genes in some Mbn operons have other predicted biosynthetic roles, and all appear to encode cytoplasmic proteins. Genes encoding PLPdependent aminotransferases (annotated mbnN) are present in some Group I and all Group IV Mbn operons (Figure 2A), although the aminotransferases in the two groups are not closely related (19,20). When mbnN is disrupted in Ms. trichosporium OB3b, no wild-type Mbn production is observed (45). A smaller compound is present, with a mass equivalent to that of the apo compound altered by C-terminal methionine loss, an N-terminal primary amine rather than a ketone, and acid hydrolysis of one of the two labile oxazolone/thioamide moieties. This compound was proposed to result from incomplete oxazolone A formation without MbnN. Given that all Mbns characterized thus far have oxazolone B (21,22,24,25), despite the absence of an aminotransferase in all Mc. Mbn operons (19), it is unclear why oxazolone A would require MbnN in the two Ms. species. Increased acid lability resulting in hydrolysis of oxazolone A is an alternative interpretation.
As with MbnN, the role of a cytoplasmic PAPS-dependent sulfotransferase (MbnS) is relatively straightforward. It is found only in Group IIa Mbn operons (19), which encode Mbns containing a sulfonated threonine (22,25), and is predicted to perform that post-translational modification. An NAD(P)H-dependent flavoenzyme (MbnF) may play a role in heterocycle biosynthesis in some Group I and II Mbns (19,20), catalyzing the transformation of the oxazolone A to a (hydroxy)pyrazin(edi)one. The closest characterized relatives are monooxygenases that carry out hydroxylation reactions (46), but it is unclear whether MbnF modifies Mbn intermediates similarly. Alternatively, MbnF may be involved in an oxidation step in oxazolone biosynthesis (47), although Ms. trichosporium OB3b and Ms. sp. LW4 Mbn operons lack MbnFs, but produce oxazolonecontaining Mbns (19,21,24).
Two cytoplasmic biosynthesis proteins have unpredicted roles. A gene annotated as a dioxygenase (mbnD) follows mbnF in Group IIb operons, but no Mbns from these operons have been characterized so its role in Mbn biosynthesis is unclear (19). A distant relative of MbnB, MbnX, is encoded in Group V operons, with mbnX immediately following mbnA and translationally coupled with mbnB, mbnC, and mbnM (19). In the absence of characterized Mbns encoded by these operons, the role of MbnX is unclear. Notably, no identifiable protease is conserved in Mbn operons. Cytoplasmic enzymes such as MbnN and MbnF are predicted to carry out modifications requiring prior leader peptide loss, meaning leader peptide loss must occur in the cytoplasm, but it is unknown when and how this loss occurs.
Finally, a pair of proteins encoded in many Mbn operons, MbnH, a di-heme cytochrome c peroxidase and MbnP, a tryptophan-rich protein from no identifiable family, have also been proposed to play a role in oxazolone biosynthesis (47). However, these proteins have genes more closely associated with Mbn import machinery (19,48), are periplasmic unlike all other cytoplasmic biosynthesis enzymes (20), and are not present in the operon of at least one characterized Mbn (24). Their function has not been investigated experimentally.

Mbn transport
Uptake of intact CuMbn was demonstrated using isotopic and fluorescent labeling, and competition experiments with apo Mbn provided evidence for the existence of a specific transporter (49). This transporter was hypothesized to belong to the TonB-dependent transporter (TBDT) family (41), members of which import siderophores and other compounds across bacterial outer membranes and into the periplasm (50), powered by the proton-motive force (51). Experiments using spermine as a passive transport inhibitor and CCCP as an active transport inhibitor confirmed that CuMbn is taken up actively via a process distinct from the passive and likely porin-dependent uptake of soluble copper compounds such as CuCl 2 and CuSO 4 , although copper uptake via either pathway can increase cellular copper and affect copper-dependent gene regulation (49).
TonB-dependent transporters are present in four of the five Mbn operon groups (19). The exceptions are Group V operons, which are predicted to produce divergent Mbns that may have roles other than copper uptake. TBDTs in Mbn operons belong to three distinct phylogenetic groups, of which none belong to known TBDT subfamilies (48). Group I Mbn operons contain MbnT1s with an N-terminal extension involved in trans-periplasmic interactions with innermembrane anti-σ factors (52). Analogous to the FecIRA system, in which uptake of iron citrate through FecA (the TBDT) triggers an interaction with FecR (the anti-σ factor) which then activates FecI (the σ factor) to increase the expression of the FecIRA (and other) genes (53), MbnT1mediated transport and regulation may be coupled (Figure 3). MbnT1s are found primarily in methanotrophs and ammonia oxidizers, including many species that lack Mbn operons, suggesting that Mbn piracy may occur. The MbnT2s in Group II Mbn operons and the MbnT3s in Group III and IV operons lack N-terminal extensions and are not associated with regulatory components (48).
MbnT function has been verified experimentally. Disruption of the Ms. trichosporium OB3b mbnT gene effectively eliminates import of CuMbn, but not soluble copper (48,54), and heterologous expression of MbnT in E. coli enables these bacteria to take up CuMbn (48). Two other copper-repressed non-operon mbnIRTPH clusters are present in the Ms. trichosporium OB3b genome, but their regulatory patterns differ from the operon mbnIRTPH genes, and their products do not appear to substitute for the Mbn operon mbnIRT. Multiple MbnT homologues may offer separate uptake paths for non-native Mbns as in siderophore piracy. However, surface plasmon resonance experiments indicate that non-native Mbns can bind (if not necessarily be transported by) MbnTs (48).
Some Group I and II Mbn operons encode periplasmic binding proteins (PBPs), termed MbnEs, that interact with periplasmic CuMbns (48). MbnEs are related to oligopeptide-binding PBPs like OppA and AppA, which are members of SBP Family 5 (55) and are part of oligopeptide ABC transport systems, conveying peptides to inner membrane import systems after their initial uptake across the outer membrane and into the periplasm. Unlike genes for related PBPs such as yejA, whose product binds the peptidic natural product microcin C7 (56), mbnEs are copperregulated like the Mbn operon, even if they are not in its immediate genomic proximity (48). The crystal structure of Mc. parvus OBBP MbnE (48) exhibits a substrate binding cavity as large as that of the nonapeptide-binding AppA (57), consistent with a role in Mbn binding. Multiple heterologously expressed and immobilized MbnEs bind native Mbns, but unlike MbnTs, no binding of non-native Mbns is observed (48). Since mbnEs lack neighboring ABC transporter genes, it is unclear whether MbnEs share an ABC transport system with oligopeptide-binding PBPs or whether they play a role unrelated to cytoplasmic uptake of intact CuMbn.
The uncertainty regarding the fate of internalized Mbn extends to Mbn copper release. Some siderophores are degraded during metal release (58), but many siderophores are recycled, including pyoverdine, carboxymycobactin, and ferrichrome (59-61). For some siderophores, iron reduction allows proteins with higher Fe(II) affinities to remove the metal without metallophore modification (62). In Mbns, bound copper could conceivably be oxidized to Cu(II). Periplasmic copper proteins commonly encoded by Mbn operons, like CopC (63) and DUF461 (64), might ultimately bind the oxidized copper, but are unlikely to be the oxidases. However, most Mbn Group I-IV Mbn operons contain mbnH and mbnP (19). Their association with mbnT genes suggests a role related to Mbn import (19,20) that could possibly involve copper release.
Mbn export is not yet well characterized. Four of the five Mbn operon groups, including the divergent Group V operons, contain genes encoding inner membrane efflux pumps, MbnMs, belonging to the multidrug and toxic compound extrusion (MATE) family (19). These H + /Na + antiporters mediate the efflux of cationic xenobiotic compounds across the inner membrane and into the periplasm (65, 66), but are poorly understood, and their outer membrane partners are unidentified. A role for MATE proteins in the export of native natural products such as Mbns would be new, but is suggested by the conservation of MbnM in the large majority of Mbn operons.

Regulation of Mbn in methanotrophs
In methanotroph copper homeostasis, sMMO and pMMO are reciprocally regulated by copper (the copper switch) (67). Expression and proteomic analysis of multiple species supports significant down-regulation of sMMO in the presence of copper, while most studies show that pMMO is mildly up-regulated (67-71). Since Mbn secretion was first observed at low copper in wildtype methanotrophs (72,73) or in variant strains with a constitutively copper-starved phenotype (74,75), and since there should be no need for Mbn production in the presence of abundant bioavailable copper, the Mbn operon was expected to be copper-repressed. An extensive set of qRT-PCR experiments, involving several timepoints after the addition of copper to copper-starved Ms. trichosporium OB3b cells, confirmed that the entire Mbn operon in that species is copperregulated, along with the mbnE gene, despite separation from the main operon (71). Furthermore, the Mbn and sMMO operons are co-regulated, with swift co-repression of the regulatory genes followed by a slower decrease in main operon transcription, perhaps as existing regulatory proteins degrade and are not replaced. Additional studies identified significant but non-identical copper down-regulation patterns in non-operon mbnIRTPH gene clusters (48). Recent RNA-Seq studies under low and high copper conditions lack the time resolution of the qRT-PCR studies, but support these expression patterns (76).
The regulatory protein(s) that repress the Mbn and sMMO operons in the presence of copper have not been identified. CuMbns may be a direct signaling factor in species with MbnT1s, but the copper switch occurs in organisms lacking Mbn operons, ruling out involvement of anything Mbn-related (including MbnI and Mbn/CuMbn itself (47)) as the copper switch regulator. MmoD, a protein of unknown function encoded in the sMMO operon, has also been suggested as a regulator, potentially in tandem with Mbn/CuMbn (42,47). However, biological support for this hypothesis relies on knockouts of most of the sMMO operon (42), or of MmoD alone (77), and in vitro biochemical evidence suggests that MmoD interacts with and affects the activity of sMMO (78). Knockout of major metabolic enzymes can cause significant metabolic rewiring (79), so the extent to which phenotypic effects reflect copper switch perturbation versus disruption of sMMO activity remains unclear. There is also no evidence that MmoD binds DNA, copper, or Mbn/CuMbn (71,80). Despite claims to the contrary (47), MmoD transcription is strongly copper-repressed in several species (70,71,76), which is incompatible with several regulatory schemes. Finally, the overlap between species producing sMMO, pMMO, and Mbn is quite small (20). A yet-to-beidentified copper-responsive regulator remains the most likely candidate for the copper switch in methanotrophs (Figure 3). Regulation of Mbn operons in non-methanotrophs has yet to be investigated.

Broader roles for Mbns
Mbn research has historically focused on its role in methanotroph copper homeostasis. However, most Mbn operons are found in nonmethanotrophs, and remain unstudied. Nevertheless, the content of non-methanotrophic Group III and IV Mbn operons supports a role in copper homeostasis (20). CopC (a periplasmic copperbinding protein) and CopD (an inner-membrane copper transporter) are involved in copper uptake (81), and are encoded in many Mbn operons. Genes encoding other periplasmic copper binding proteins are also frequently present, including Sco1 (commonly involved in cytochrome c oxidase copper loading (82)) as well as the poorly understood DUF461 (83) and DUF2946 proteins, the latter of which is MbnT-associated. The pres-ence of so many genes encoding periplasmic copper-binding proteins in Mbn operons is suggestive of a role in copper homeostasis for nonmethanotrophs. By contrast, Group V operons lack both importers and copper binding proteins (19), suggesting that these Mbns may have a completely different function, perhaps acting as antibiotics.
Mbns might also play a role in protection against toxicity of metal ions other than copper. Copper binding by the siderophore yersiniabactin is believed to shield pathogens from copper toxicity during infection (84). Mbn chelation of Hg(II) and Au(III) has been proposed to have a similar function (39,85). However, it is unclear whether this broader-spectrum metal binding is biologically relevant for most methanotrophs, which live in a wide range of environments, most of which are not contaminated with heavy metals. Similar caveats apply to methylmercury demethylation, in which Mbn has been proposed to play a role, possibly replacing MerA via reductive binding (86). Mbn-mediated production of gold nanoparticles has also been reported (87)(88)(89). Sequestration of toxic gold via nanoparticle production is observed in several species (90) and can be mediated by the natural product delftibactin in Delftia avidovorans (91). It is conceivable that Mbn-derived nanoparticle production is a means of defense against unwanted metals. Finally, CuMbn has been reported to exhibit superoxide dismutase, oxidase, and hydrogen peroxide reductase activities (92,93). Since bacterial secretion of superoxide can be a source of environmental oxidative stress (94), extracellular superoxide dismutase activity mediated by secreted natural products may be biologically relevant.
In terms of potential applications, CuMbn from Ms. trichosporium OB3b has been reported to exhibit antibiotic activity against Gram-positive bacteria (95). Mbn has also been investigated as a treatment for Wilson disease, a human disorder of impaired copper efflux and toxic copper accumulation (96). Existing treatments are limited and most have significant side effects, fail to liberate some bound forms of copper, or bind problematic amounts of other biologically relevant metals (97). In a rat model, Mbn reversed the acute liver failure associated with copper overload (98). Mbns or Mbn analogues are thus of significant interest as copper chelating drug candidates. Once it is better understood, the modular Mbn RiPP biosynthetic machinery can be deployed to produce nonnatural Mbns, using rational design and high throughput screening to adjust chemical properties in a search for bioactive compounds. Similar techniques have already been used in other RiPP systems, including the cyanobactins (99).

Conclusions
Mbns play a key role in methanotroph copper homeostasis, and efforts to elucidate that role are important to attempts to bioengineer these organisms. However, it is clear that copper uptake mediated by these compounds is relevant far beyond methanotrophs. Future Mbn research will require a reassessment of bacterial copper homeostasis, both in the broader environment and at the host-pathogen interface. Characterization of Mbns from a wider range of species will yield additional dividends as new post-translational modifications and biosynthetic mechanisms are identified, and any resulting bioactive compounds are investigated as drug candidates and ultimately reengineered for increased activity. The history of Mbns may be defined by methanotrophy, but their future lies in the broader bacterial world.